Article info
PDFInflammatory bowel disease
Original article
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Correspondence to Prof Dr Stephan Brand, Department of Medicine II, University-Hospital Munich-Grosshadern, Ludwig Maximilians University Munich, Munich D-81377, Germany; stephan.brand{at}med.uni-muenchen.de
Citation
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
Publication history
- Received May 4, 2012
- Revised January 21, 2013
- Accepted February 7, 2013
- First published March 6, 2013.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions